Collectively, the experimental data demonstrated that miR-202-3p harbored tumor-suppressive properties during the development and progression of HCC through the KDM3A/HOXA1/MEIS3 axis in vitro and in vivo. Here, MEIS3 is linked to hepatocellular carcinoma.